Survodutide
$165.00
What is Survodutide?
Survodutide is an investigational dual agonist targeting both the glucagon receptor (GCGR) and the glucagon-like peptide-1 receptor (GLP-1R). Developed by Boehringer Ingelheim and Zealand Pharma, it has been studied in preclinical and early clinical models for its potential effects on metabolic regulation, including energy balance and body weight modulation. Research has focused on its relevance to obesity and metabolic dysfunction-associated steatohepatitis (MASH), with ongoing studies exploring its mechanisms of action and therapeutic potential. For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.
Volume: 3mL
Category: Metabolic Research
Related products
-
Sale!
Select options This product has multiple variants. The options may be chosen on the product pageRetatrutide
$55.00 – $180.00Price range: $55.00 through $180.00 -
Sale!
Select options This product has multiple variants. The options may be chosen on the product pageSLU-PP 332
$60.00 – $200.00Price range: $60.00 through $200.00 -
Sale!
Tirzepatide
$100.00Original price was: $100.00.$65.00Current price is: $65.00. -
Sale!
Select options This product has multiple variants. The options may be chosen on the product pageSemaglutide
$21.00 – $65.00Price range: $21.00 through $65.00



There are no reviews yet.